Get startedLog in
    Picture of Innovation Pharmaceuticals logo

    IPIX — Innovation Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Innovation Pharmas' Brilacidin Reduces Viral Titer Of Sars-Cov-2 (Covid-19) By 75% After Only 1 Hour Of Preincubation In In Vitro Study At Bsl-3 Facility

    Picture of Innovation Pharmaceuticals logoInnovation Pharmaceuticals
    19/05/2020 12:54
    May 19 (Reuters) - Innovation Pharmaceuticals Inc  IPIX.PK :
    * INNOVATION PHARMACEUTICALS’ BRILACIDIN REDUCES VIRAL TITER
OF
SARS-COV-2 (COVID-19) BY 75 PERCENT AFTER ONLY 1 HOUR OF
PREINCUBATION IN IN VITRO STUDY AT BSL-3 FACILITY; DEMONSTRATES
POTENT AND RAPID VIRUCIDAL ACTIVITY

Source text for Eikon:  ID:nGNX6SndPX 
Further company coverage:  IPIX.PK 

 (Reuters.Briefs@thomsonreuters.com)

    Recent news on Innovation Pharmaceuticals

    See all news